Disease Management Apps Market (By Platform Type: iOS, Android, Others; By Device: Smartphones, Tablets, Wearables; By Indication) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global disease management apps market was surpassed at USD 4.23 billion in 2022 and is expected to hit around USD 17.19 billion by 2032, growing at a CAGR of 15.04% from 2023 to 2032.

Disease Management Apps Market Size 2023 to 2032

Key Pointers

  • By Platform Type, both iOS and Android have dominated the market in recent years.
  • By Device, smartphones have dominated the market in recent years.
  • In recent years, diabetes management apps have been one of the most dominant subsegments in the disease management apps market. 
  • Mental health management apps have also been growing in popularity in recent years.

Report Scope of the Disease Management Apps Market

Report Coverage Details
Market Size in 2022 USD 4.23 billion
Revenue Forecast by 2032 USD 17.19 billion
Growth rate from 2023 to 2032 CAGR of 15.04%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Healthy.io, Medicounty, MYFITNESSPAL, NOOM INC., FITBIT, INC., AZUMIO INC., Sleep Cycle, other


The disease management apps market is expected to grow at a significant rate owing to a growing trend of individuals prioritizing a healthy lifestyle. The widespread use of tablets, wearable technology, and smartphones, along with the existence of mobile apps, is also driving the market growth. The rising public consciousness about the health risks associated with poor nutrition is boosting demand for apps that help manage lifestyle diseases. A study by the World Economic Forum, published in September 2020, found that the market for fitness apps has experienced a growth of over 45% globally in terms of downloads and is expected to continue to grow as more individuals adopt smart devices, smart wearables, and smartphones. The COVID-19 pandemic resulted in lockdowns and social distancing measures, resulting in a shift from traditional healthcare settings to virtual healthcare, which boosted the demand for these apps. The pandemic further accelerated the adoption of digital health solutions and is expected to drive the growth of the disease management apps market in the coming years.

Disease management apps are software applications designed to help individuals manage their chronic illnesses and conditions. These apps typically provide tools and resources to track symptoms, manage medication, communicate with healthcare providers, and access educational information about the disease. They also often feature reminders, goal-setting and tracking, and access to community resources or support groups. The aim is to help patients better understand and manage their condition, improve health outcomes, and promote self-care. The consumer focus is shifting toward the management of chronic diseases such as diabetes, heart disease, and mental health conditions. Healthcare providers are increasingly adopting and integrating disease management apps into their practices to improve patient outcomes and reduce costs. These trends highlight the growing importance of digital health solutions in the management of chronic diseases and the drive to provide more personalized, convenient, and effective care to patients.

The integration of telemedicine into disease management apps is becoming increasingly popular, allowing patients to connect with healthcare providers remotely. Companies are incorporating AI and machine learning into their disease management apps to provide personalized recommendations and improve health outcomes, they are also integrating wearable technology, such as fitness trackers and smartwatches, into disease management apps to provide a more comprehensive view of a patient's health. For instance, in December 2020, Otsuka Pharmaceutical, a Japanese pharmaceutical company, acquired Proteus Digital Health, a digital health company. This acquisition will enable Otsuka Pharmaceutical to integrate Proteus' digital medicine technology into its existing portfolio of psychiatric and neurological drugs and provide patients with a more comprehensive and personalized approach to their health management. The acquisition will also enhance its capabilities in digital health and expand its reach in the growing market for connected health solutions.

Disease Management Apps Market Segmentations:

By Platform Type By Device By Indication







Chronic Diseases

Cardiovascular diseases


Respiratory diseases


Inflammatory conditions

Mental health conditions

Other conditions

Frequently Asked Questions

The global disease management apps market size was reached at USD 4.23 billionin 2022 and it is projected to hit around USD 17.19 billion by 2032.

The global disease management apps market is growing at a compound annual growth rate (CAGR) of 15.04% from 2023 to 2032.

Key factors that are driving the disease management apps market growth include rising need for solutions to reduce healthcare costs, increasing focus on patient-centric care, and strong government support.

Report Detail

Proceed To Buy

USD 3500
USD 7000

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers